CDK4/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancer.
Auteurs : Agostinetto E, Debien V, Marta GN, Lambertini M, Piccart-Gebhart M, de Azambuja E
Jaar : 2021
Journal : Eur J Clin Invest
Pagina's : e13535